Indaptus Therapeutics INDP
NASDAQ INDP
$1.27 -0.11 (-7.97%)
As of: Aug 21, 2026 · 11:33 AM EDT

Indaptus Therapeutics (INDP) Tax Provisions (2020 - 2021)

Indaptus Therapeutics (INDP) posted quarterly Tax Provisions of $13000.0 for Q2 2021, down 71.74% year-over-year from $46000.0 in Q2 2020, and down 35.0% quarter-over-quarter from $20000.0 in Q1 2021.

Indaptus Therapeutics (INDP) Tax Provisions (2020 - 2021) Analysis & Trends

Indaptus Therapeutics' Tax Provisions history runs 2 years deep, the most recent figure standing at $13000.0 for Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 139.95 Bn 132.10 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 86.71 Bn 78.72 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 65.71 Bn 60.52 Bn 1.37 Bn 59.00 Mn
4 Moderna 60.45 Bn 55.31 Bn 52.00 Mn 15.00 Mn
5 BeOne Medicines 42.24 Bn 37.14 Bn 1.53 Bn 75.45 Mn
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn 13.31 Mn
7 BioNTech SE 28.64 Bn 10.25 Bn 668.28 Mn -90.33 Mn
8 Insmed 27.61 Bn 26.45 Bn 358.27 Mn 1.90 Mn
9 Royalty Pharma 27.26 Bn 26.42 Bn - -
10 Indaptus Therapeutics 147.49 Mn 135.93 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 13,000.00
Mar 31, 2021 20,000.00
Jun 30, 2020 46,000.00
Mar 31, 2020 61,000.00